Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 8, 2017, Pages 2378-2384

  Nascimento Carvalho, Cristiana M ^a   Xavier Souza, Gabriel ^a   Vilas Boas, Ana Luisa ^a   Fontoura, Maria Socorro H ^a   Barral, Aldina ^b   Puolakkainen, Mirja ^c   Ruuskanen, Olli ^d   Matutino, Adriana R ^a   Barreto, Bruna B ^a   Silva, Carolina C ^a,e   Braga, Daniel A ^a   Oliveira, Felipe ^e   Nogueira, Giorgio V ^a   Oliveira, Ícaro S ^a   Lorgetto, Igor ^e   Costa, Itana N ^e   Araripe, Jamile ^e   Vieira, Júlia R ^e   Neiva, Lais B ^a   Noblat, Lúcia ^a   Santana, Milena C ^a   Nobre Bastos, Monalisa ^a   Santos, Pablo M ^a   Câmara, Sérgio F ^a   Carneiro, Solange ^a   Sirmos, Uri R ^a   Araújo, Vital F ^a   Vilas Boas, Caroline ^a   Gantois, Denise ^e   Azevedo, Fausto ^a   Maia, José Raimundo ^a   Pirajá, Larissa ^a   Jesus, Priscila S ^a   Fonseca, Taiane ^a   Vilar, Ticiana ^a   more..

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e Bahia Foundation for Science Development   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CHLAMYDIA PNEUMONIAE; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL PNEUMONIA; CHLAMYDIASIS; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; CONVALESCENCE; DEATH; DISEASE DURATION; DISEASE SEVERITY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FOLLOW UP; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; OUTCOME ASSESSMENT; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT FAILURE; BACTERIAL PNEUMONIA; CHLAMYDIA; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOPLASMA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CHLAMYDIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MYCOPLASMA; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES;

EID: 85027193897     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx126     Document Type: Article

References (31)

1. Madhi SA, De Wals P, Grijalva CG et al. The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J 2013; 32: e119-27.
2. Walker CL, Rudan I, Liu L et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381: 1405-16.
3. Liu L, Oza S, Hogan D et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post- 2015 priorities: an updated systematic analysis. Lancet 2015; 385: 430-40.
4. Gilani Z, Kwong YD, Levine OS et al. A literature review and survey of childhood pneumonia etiology studies: 2000-2010. Clin Infect Dis 2012; 54 Suppl 2: 102-8.
5. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986; 5: 247-52.
6. Nascimento-Carvalho CM, Madhi SA, O'Brien KL. Review of guidelines for evidence-based management for childhood community-acquired pneumonia in under-5 years fromdeveloped and developing countries. Pediatr Infect Dis J 2013; 32: 1281-2.
7. Principi N, Esposito S, Blasi F et al. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32: 1281-9.
8. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for communityacquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2015; issue 1: CD004875.
9. Pan American Health Organization. Regional report of SIREVA II, 2012: Data by country and by age strata on the characteristics of strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis isolated from invasive disease. [Organização Panamericana de Saúde. Informe Regional de SIREVA II, 2012: Datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, em procesos invasores]. 2013. http://iris.paho.org/xmlui/handle/ 123456789/31147.
10. Vilas-Boas AL, Fontoura MS, Xavier-Souza, G et al. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59months old with non-severe pneumonia: a randomized controlled trial. J Antimicrob Chemother 2014; 69: 1954-9.
11. Nascimento-Carvalho CM, Souza-Marques HH. Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Rev Panam Salud Publica 2004; 15: 380-7.
12. Cherian T, Mulholland EK, Carlin JB et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies.BullWorldHealthOrgan2005; 83: 353-9.
13. Gencay M, Koskiniemi ML, Ammala P et al. Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS 2000; 108: 584-8.
14. El-Radhi AS, Barry W. Thermometry in paediatric practice. Arch Dis Child 2006; 91: 351-6.
15. WHO. Pocket Book of Hospital Care for Children. Guidelines for the Management of Common Childhood Illnesses, 2nd edn. 2013. http://www.who. int/maternal_child_adolescent/documents/child_hospital_care/en/index.html.
16. WHO. Training Course on Child Growth Assessment. 2008. http://whqlib doc.who.int/publications/2008/9789241595070_A_eng.pdf.
17. Leyenaar JK, Shieh MS, Lagu T et al. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia. Pediatr Infect Dis J 2014; 33: 387-92.
18. Ambroggio L, Taylor JA, Tabb LP et al. Comparative effectiveness of empiric b-lactam monotherapy and b-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. J Pediatr 2012; 161: 1097-103.
19. Mills GD, Oehley MR, Arrol, B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community-acquired pneumonia:meta-analysis. BMJ 2005; 330: 456.
20. Biondi E, McCulloh R, Alverson B et al. Treatment of mycoplasma pneumonia: a systematic review. Pediatrics 2014; 133: 1081-90.
21. Colin AA, Yousef S, Forno E et al. Treatment of Mycoplasma pneumoniae in pediatric lower respiratory infection. Pediatrics 2014; 133: 1124-5.
22. Youn YS, Lee SC, Rhim J Wet Al. Early additional immune-modulators for Mycoplasma pneumoniae pneumonia in children: an observation study. Infect Chemother 2014; 46: 239-47.
23. Nilsson AC, Jensen JS, Bjorkman P et al. Development ofmacrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides. Scand J Infect Dis 2014; 46: 315-9.
24. Zhou Y, Zhang Y, Sheng Y et al. More complications occur in macrolideresistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 2014; 58: 1034-8.
25. Atkinson TP,Waites KB. Mycoplasma pneumoniae infections in childhood. Pediatr Infect Dis 2014; 33: 92-4.
26. Spuesens EB, Fraaij PL, Visser EG et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS One 2013; 10: e1001444.
27. Wood PR, Hill VL, Burks ML et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol 2013; 110: 328-34.el.
28. Volanen I, Vainionpaa R, Ilonen J et al. A prospective study of Chlamydia pneumoniae antibodies in children between 7months and 8 years of age. Scand J Infect Dis 2003; 35: 471-7.
29. Normann E, Gnarpe J, Gnarpe H et al. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 1998; 87: 23-7.
30. Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503.
31. Schachter J, Grossman M, Azimi PH. Serology of Chlamydia trachomatis in infants. J Infect Dis 1982; 146: 530-5.